Gamma Therapeutics executive management team and consultants is comprised of experienced life science business executives and scientists with broad and in depth experience in hemostasis, thrombosis and coagulation research; pathology and diagnostic testing; military medicine and combat casualty care; trauma surgery and medicine; FDA regulatory process; product development, marketing and launch; life science venture management; business development; strategic partnering; channel sales relationships, and; international distribution.
David Farrell, PhD, Founder & Chief Scientific Officer:
33-year researcher in the areas of hemostasis, thrombosis and coagulation, 18 years as a Principal Investigator; Professor of Surgery, Department of Surgical Medicine, Oregon Health & Science University; Director, Health Sciences Technology Entrepreneurship Certificate Program; Fellow, American Heart Association; B.S. in Biochemistry, UCLA, Ph.D. in Biological Sciences, University of California, Irvine; Former Asst. Professor Biochemistry & Molecular Biology, Penn State College of Medicine; and, former Chair, SBIR grants study section, National Institutes of Health.
David F. Eastman, MS, Chief Executive Officer:
35-year experienced Life Science industry executive developing products and launching start-up ventures in medical systems, software, biotechnology and medical devices. Formerly CEO of Yecuris Corporation, a venture start-up developing humanized mouse models for drug discovery; executive product marketing manager at Becton Dickinson, Fresenius Corporation and Cordis Dow Medical; consultant for 26 medical device start-ups; Co-Chair, OHSU Start-Up Advisory Group; BOD, OmnEcoil, MagnetoOrganics & NeuraMedica; B.S. in Marketing and Communications, University of Northern Colorado; M.S., Business, Marketing and Design, University of Oregon; Executive MBA Medical Product Marketing Certificate Program, UCLA Anderson School of Management.
Copyright © 2010, Gamma Therapeutics, Inc. All rights reserved.